Диссертация (1139730), страница 56
Текст из файла (страница 56)
Feigenbaum, A.V. Total Quality Control / A. V. Feigenbaum – McGraw-Hill, 1961,1983, 1991. – 851 p.259. Friedman, T. The World is Flat: A Brief History of the Twenty-first Century / T.Friedman. – Farrar, Straus and Giroux, 2005. – 488 p.260. Grissenger, M. Avoiding confusion with alphabetic characters / M. Frissenger // P&T.
–2012, 37. - PP. 665-667.261. Good pharmacy practice (GPP) in community and hospital pharmacy settings. Geneva.[Electronicversion].WHO,1996(WHO/PHARM/DAP/96.1)–8p.URL.:Обращениеhttp://apps.who.int/medicinedocs/documents/s21088en/s21088en.pdf.08.02.2016.262. Good pharmacy practice in Europe. Pharmaceutical Group of the European Union PGEU.- Community pharmacists. - 1998. – 9 p.263. Good Pharmacy Practice. Joint FIP/WHO Guidelines on GPP: Standards for quality ofpharmacy services from the WHO technical report series, N 961, 45th report of the WHOExpert Committee on specifications for pharmaceutical preparations [Electronic version].WHO.2011–16p.URL.:http://whqlibdoc.who.int/trs/WHO_TRS_961_eng.pdfОбращение 26.08.2015.264. Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance.
[Electronicversion].-ICH–April1996.–63p.305https://www.fda.gov/downloads/drugs/guidances/ucm073122.pdfОбращение10.04.2016.265. Guide to good storage practices for pharmaceuticals. WHO Expert Committee onSpecifications for Pharmaceutical Preparations совместно c International PharmaceuticalFederation (FIP). WHO Expert Committee on Specifications for PharmaceuticalPreparations. Thirty-Fourth Report. – Geneva. –World Health Organization. - 2003. Annex 9 (WHO Technical Report Series N 908). – 10 p.266. Guide to good manufacturing practice for medicinal products. Pharmaceutical InspectionConvention.
Pharmaceutical Inspection Co-operation Scheme [Electronic version]. – PE009 – 1 September 2009. URL.: http://www/picscheme.org. Обращение 09.04.2015.267. Guidelines on good distribution practice of medicinal products for human use (94/C63/03).
The Rules Governing Medicinal Products in the European Union, Volume I. Luxembourg, Office for Officinal Publications of the European Communities, 1995. – PP.133-137.268. Guideline on declaration of storage condition: А: in the product information of medicinalproducts; В: for active substances. ЕМЕА. London, 2007; CPMP/QWP/609/96/Rev2. – 4p.269. Guidelines.
Medicinal products for human use. Safety, environment and information.Excipients in the label and package leaflet of medicinal products for human use.European commission, Brussels. – 2003. – 10 p.270. Guideline on the readability of the label and package leaflet of medicinal products forhuman use. European commission, Brussels. – 2009. – 27 p.271. Guideline on the packaging information of medicinal products for human use authorizedby the Union.
European commission, Brussels. – 2013. – 40 p.272. Hampton, T. Similar drugs names a risky prescription / T. Hampton // JAMA. – 2004. 291/ - PP. 155-160.273. Healy, M. Consumer Representation in Standards Making / M. Healy, N. Pope //Compendium from the Third Annual EURAS (European Academy of Standardization)Conference. - Stockholm. - 1996 – 5-7 May – 29p.306274. Hoffman, JM, Proulx SM. Mediciation errors caused by confusion of drug names / JM.Hoffman, SM.
Proulx // Drug Safety. - 2002, 26. - PP. 445-452.275. Hopper, K. The Puritan Gift: Reclaiming the American Dream Amidst Global FinancialChaos. / K. Hopper, W. Hopper // I.B. Taurus, 2009. – 352 p.276. Howe, J. The rise of crowdsourcing / J. Howe // Wired magazine. – 2006. Vol.14. - № 6.– PP. 1 - 4.277. IEC 60300-3-2 ED.2.0 B:2004. Dependability management-Part 3-2: Application guide –Collection of dependability data from the field.
Standard by International ElectrotechnicalCommission, 11.10.2004. – 79 p.278. Innocenti A. Cognitive Economics in the Lab. The Power of Labels / A. Innocenti // Mindand Culture: Joint Workshop Rutgers-Siena. Certosa di Pontignano: University of Siena.– 2009. - June 1-2.279. InternationalConferenceonHarmonization.HarmonizedTripartiteGuideline.Specifications: Test Procedures and Acceptance Criteria for New Drug Substances andNew Drug Products: Chemical Substances Q6A [Electronic version]. - Current Step 4versiondated6October1999.–21p.URL.:https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q6A/Step4/Q6Astep4.pdf.
Обращение 10.03.2015.280. International Conference on Harmonization (2012). Pharmaceutical Development Q8[Electronicversion].–24p.URL.:https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf Обращение 17.06.2015.281. International Conference on Harmonization. Harmonized Tripartite Guideline. QualityRisk Management Q9. - Current Step 4 version dated 9 November 2005. [Electronicversion].–19p.URL.:http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002873.pdf Обращение 17.06.2015.282. International Conference on Harmonization.
Tripartite Guideline. Pharmaceutical QualitySystem Q10. – Current Step 4 version dated 4 June 2008. [Electronic version]. – 17 p.URL.:307https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdf. Обращение 17.06.2015.283. International Pharmaceutical Federation. FIP statement of policy on counterfeitmedicines. Approved by FIP Council in Sydney in September 2003. [Electronic version].URL.: http://www.fip.nl/statements Обращение 10.06.2015.284.
ISO 31000:2009 (en). Risk management. - Principles and guidelines. ISO:03.100.01.Published TC/SC. ISO.ITC.262. - 2013-12-18. - 24 p.285. Joseph, Miny Wah Li. Models for Inter-disciplinary Education of HealthcareProfessionals [Electronic version]. - International Pharmaceutical Federation CentennialCongress of Pharmacy and Pharmaceutical Sciences: Amsterdam. October 2012.
SessionImprovingpatientoutcomesthroughcollaborativepractice.URL.:http://www.fip.org/files/abstracts/2012/Presentation2012/1A%20Ming%20Wah.pdf.Обращение 12.11.2013.286. Kelsey, FO. Thalidomide update: regulatory aspects / FO. Kelsey // Teratology/ - 1998,38. - PP. 221-226.287. Kubiak, Thomas M.
Feigenbaum on Quality: Past, Present and Future / Thomas M.Kubiak. – Quality Progress. - November 2006. - PP. 57-62.288. Levine, D. I. Quality Management and Job Quality: How the ISO 9001 Standard forQuality Management Systems Affects Employees and Employers / D.I.
Levine, M.W.Toffel // Harvard Business School. – Management Science. – June 2010. - Vol. 56. - N 6.– PP. 978-996.289. Louise-May, S. Towards integrated web-based tools in drug discovery / S. Louise-May,B. Bunin // Drug Discovery - Touch Briefings. - 2009. - Vol. 6. - PP. 17-21.290. Luhmann, N. Familiarity, confidence, trust: Problems and alternatives / Trust: Makingand breaking cooperative relations / N.
Luhmann // Ch.6. Oxford: University of Oxford. 2000. - PP. 94-107.291. MacDougall, IC. 2005. Adverse event issue management: What have we learnt from pureand red cell aplasia (PRCA)? / IC. MacDougall // Nephrol. Dial. Transplant, 2005. - 20(Suppl.8). – PP. 18-21.308292. Martens, B. The cognitive mechanics of economic development and institutional change /B. Martens. - London and New York: Routledge, 2004. – 221 p.293. Mazzei, C., Nichols D.
and Sanders C. Ernst & Young. Community Sourcing: BringingInnovations out of the Ivory Tower [Electronic version] / C. Mazzei, D. Nichols and C.Sanders.URL:http://www.wired.com/2014/10/community-sourcing-innovationОбращение 22.03.2015.294. McAllister, DJ. Affect and cognition-based trust as foundation in Organizations / DJ.McAllister // Academy of Management Journal. – 1995. - 38, 1. - PP.
24-59.295. Meadows, M. Promoting safe and effective drugs for 100 years [Electronic version] / M.Meadows // FDA Consumer Magazine. - 2006. - The Centennial Edition: JanuaryFebruary.-URL.:http://www.fda.gov/AboutFDA/WhatWeDo/History/CentennialofFDA/CentennialEdionofFDAConsumer/ucm093787.htm Обращение 23.12.2014.296. MedWatch: The FDA Safety Information and Adverse Events Reporting Program[Electronicversion].U.S.Food&DrugAdministration.URL.:www.fda.gov/Safety/MedWatch/default.htm Обращение 29.06.2015.297.
Micklewright, M. Out of another @#&*% crisis!: motivation through humiliation / M/Micklewright – ASQ, Quality Press, Milwaukee, 2010. – 252 p.298. Nordsieck, Arnold. On numerical integration of Ordinary Differential equations / A.Nordsieck // Mathematics of Computation. - 1962. - Vol. 16, No 77. - PP. 22-49.299. OECD Principles of Good Laboratory Practice Directive 87/18/EEC, Directive88/320/EEC – 14 p.300. Only just the beginning of the end of hepatitis C. // The Lancet, 383(9914).
- P.281.301. Ostrom, E. A Behavioral Approach to the Rational Choice Theory of Collective Action /E. Ostrom // American Political Science Review. - 1998. - Vol. 92. - N 1. - PP. 1-22.302. Ostrom, E. The Comparative Study of Public Economies / E. Ostrom // AmericanEconomist.
- 1998. - Vol. 42. - N 1. - PP. 3-17.303. Ostrom, E. Collective Action and the Evolution of Social Norms / E. Ostrom // Journal ofEconomic Perspectives. - 2000. - Vol. 14. - N 3. - PP. 137-158.309304. Ostrom, E. The Value-Added of Laboratory Experiments for the Study of Institutions andCommon-Pool Resources / E. Ostrom // Journal of Economic Behavior & Organization. 2006. - Vol. 61.- N 2.- PP. 149-163305. Partrigde, Dale.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
